Ghent University Academic Bibliography

Journal Article
A1
open access

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

Sandra Van Lint (UGent) , Alexander Van Parys (UGent) , Bram Van Den Eeckhout (UGent) , Niels Vandamme (UGent) , Stephane Plaisance, Annick Verhee (UGent) , Dominiek Catteeuw (UGent) , Elke Rogge (UGent) , Jennifer De Geest (UGent) , Nele Vanderroost (UGent) , et al.

(2023) MOLECULAR CANCER. 22(1).

Add to list

Journal Article
A1
open access

mRNA in cancer immunotherapy : beyond a source of antigen

Lien Van Hoecke (UGent) , Rein Verbeke (UGent) , Heleen Dewitte (UGent) , Ine Lentacker (UGent) , Karim Vermaelen (UGent) , Karine Breckpot and Sandra Van Lint (UGent)

(2021) MOLECULAR CANCER. 20(1).

Add to list

Journal Article
A1
open access

Cancer risk in immune-mediated inflammatory diseases (IMID)

Rudi Beyaert (UGent) , Laurent Beaugerie, Gert Van Assche, Lieve Brochez (UGent) , Jean-Christophe Renauld, Manuelle Viguier, Veronique Cocquyt (UGent) , Guy Jerusalem, Jean-Pascal Machiels, Hans Prenen, et al.

(2013) MOLECULAR CANCER. 12.

Add to list

Journal Article
A1
open access

ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours

Annica Wilzen, Cecilia Krona, Baldur Sveinbjornsson, Erik Kristiansson, Daniel Dalevi, Ingrid Ora, Katleen De Preter (UGent) , Raymond L Stallings, John Maris, Rogier Versteeg, et al.

(2013) MOLECULAR CANCER. 12.

Add to list

Journal Article
A1
open access

Melanoma-associated chondroitin sulfate proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo

Marco de Bruyn, Anna A Rybczynska, YunWei Wei, Michael Schwenkert, Georg H Fey, Rudi Dierckx (UGent) , Aren van Waarde, Wijnand Helfrich and Edwin Bremer

(2010) MOLECULAR CANCER. 9.

Add to list

Journal Article
A1
open access

Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols

Wipob Suttana (UGent) , Samlee Mankhetkorn, Wilart Poompimon, Ajay Palagani, Sergey Zhokhov (UGent) , Sarah Gerlo (UGent) , Guy Haegeman (UGent) and Wim Vanden Berghe (UGent)

(2010) MOLECULAR CANCER. 9.

Add to list

Journal Article
A1
open access

Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat

Meng Fang (UGent) , Sylviane Dewaele (UGent) , Yun-peng Zhao, Peter Starkel, Valerie Vanhooren (UGent) , Yue-ming Chen, Xin Ji, Ming Luo, Bao-mu Sun, Yves Horsmans, et al.

(2010) MOLECULAR CANCER. 9.

Add to list

Journal Article
A1
open access

Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma

Femke Heindryckx (UGent) , Koen Mertens (UGent) , Nicolas Charette, Bert Vandeghinste (UGent) , Christophe Casteleyn (UGent) , Christophe Van Steenkiste (UGent) , Dominique Slaets (UGent) , Louis Libbrecht (UGent) , Steven Staelens (UGent) , Peter Starkel, et al.

(2010) MOLECULAR CANCER. 9.

Add to list

Journal Article
A1
open access

P-cadherin counteracts myosin II-B function : implications in melanoma progression

Koen Jacobs (UGent) , Mireille Van Gele (UGent) , Ramses Forsyth (UGent) , Lieve Brochez (UGent) , Barbara Vanhoecke (UGent) , Olivier De Wever (UGent) and marc bracke

(2010) MOLECULAR CANCER. 9.

Academic Bibliography

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

mRNA in cancer immunotherapy : beyond a source of antigen

Cancer risk in immune-mediated inflammatory diseases (IMID)

ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours

Melanoma-associated chondroitin sulfate proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo

Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols

Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat

Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma

P-cadherin counteracts myosin II-B function : implications in melanoma progression

Contents

Support

Contact